Literature DB >> 28722017

The role of age-related T-cell differentiation in patients with renal replacement therapy.

Matthias Schaier1, Angele Leick2, Lorenz Uhlmann3, Florian Kälble1, Volker Eckstein4, Anthony Ho4, Stefan Meuer5, Karsten Mahnke6, Claudia Sommerer1, Martin Zeier1, Andrea Steinborn2.   

Abstract

Dialysis patients have deficiencies regarding the generation of immune responses and show an increased susceptibility for infections. Persisting uremic conditions are made responsible for the increased aging of their immune system. In this study, we analyzed whether age-related differences in the differentiation of both recent-thymic-emigrant-(RTE)-regulatory (Tregs) and RTE-responder T cells (Tresps) into CD31--memory Tregs/Tresps led to differences in the suppressive activity of naive and memory Tregs on autologous Tresps between healthy volunteers and dialysis patients. We found that regardless of age, the differentiation of RTE-Treg/Tresps into CD31--memory-Treg/Tresps was significantly increased in dialysis patients. By analyzing the age-related differences in the differentiation of Tregs/Tresps, we saw that in healthy volunteers RTE-Tregs differentiate via CD31+-memory Tregs into CD31--memory Tregs, which may strengthen the suppressive activity of the total Treg pool. In contrast RTE-Tresps of healthy volunteers differentiate via mature naive (MN)-Tresps into CD31--memory-Tresps, which may weaken the reactivity of the total Tresp pool. Our data revealed that this normal differentiation via MN-Tresps was lost in dialysis patients, suggesting that their Tresps are less sensitive to Treg-mediated immunosuppression. Functional analysis of Tregs on autologous Tresps showed an increasing suppressive activity with age in healthy individuals, who therefore may have a lower risk of developing autoimmune diseases but owing to decreased reactivity of their Tresps are more likely to suffer from infections. In contrast, dialysis patients exhibited a decreasing suppressive activity with age, owing to strengthened Tresp reactivity, which could explain the higher prevalence of chronic inflammatory conditions in these patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28722017     DOI: 10.1038/icb.2017.57

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  36 in total

Review 1.  A killer on the road: circulating CD4(+)CD28null T cells as cardiovascular risk factor in ESRD patients.

Authors:  Michiel G H Betjes; Ruud W J Meijers; Lucia E A de Wit; Nicolle H R Litjens
Journal:  J Nephrol       Date:  2012 Mar-Apr       Impact factor: 3.902

2.  Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation.

Authors:  David Berglund; Olle Korsgren; Tomas Lorant; Karin Schneider; Gunnar Tufveson; Björn Carlsson
Journal:  Transpl Immunol       Date:  2011-09-20       Impact factor: 1.708

3.  Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients.

Authors:  Edith M Simmons; Anthony Langone; M Tugrul Sezer; John P Vella; Peter Recupero; Jason D Morrow; T Alp Ikizler; Jonathan Himmelfarb
Journal:  Transplantation       Date:  2005-04-27       Impact factor: 4.939

Review 4.  tTregs, pTregs, and iTregs: similarities and differences.

Authors:  Ethan M Shevach; Angela M Thornton
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

5.  Premature aging of circulating T cells in patients with end-stage renal disease.

Authors:  Michiel G H Betjes; Anton W Langerak; Ashley van der Spek; Elly A de Wit; Nicolle H R Litjens
Journal:  Kidney Int       Date:  2011-04-27       Impact factor: 10.612

Review 6.  Immune cell dysfunction and inflammation in end-stage renal disease.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

7.  The pattern of excess cancer in dialysis and transplantation.

Authors:  John H Stewart; Claire M Vajdic; Marina T van Leeuwen; Janaki Amin; Angela C Webster; Jeremy R Chapman; Stephen P McDonald; Andrew E Grulich; Margaret R E McCredie
Journal:  Nephrol Dial Transplant       Date:  2009-07-08       Impact factor: 5.992

8.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

9.  Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels.

Authors:  Anke Heigele; Simone Joas; Kerstin Regensburger; Frank Kirchhoff
Journal:  Retrovirology       Date:  2015-10-09       Impact factor: 4.602

10.  Influence of hemodialysis on circulating CD4(low)CD25 (high) regulatory T cells in end-stage renal disease patients.

Authors:  Katarzyna A Lisowska; Alicja Dębska-Ślizień; Aleksandra Jasiulewicz; Ewa Bryl; Jacek M Witkowski
Journal:  Inflamm Res       Date:  2013-11-05       Impact factor: 4.575

View more
  3 in total

1.  Chronic Kidney Failure Provokes the Enrichment of Terminally Differentiated CD8+ T Cells, Impairing Cytotoxic Mechanisms After Kidney Transplantation.

Authors:  Jonas Leonhard; Matthias Schaier; Florian Kälble; Volker Eckstein; Martin Zeier; Andrea Steinborn
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

2.  End-stage renal disease, dialysis, kidney transplantation and their impact on CD4+ T-cell differentiation.

Authors:  Matthias Schaier; Angele Leick; Lorenz Uhlmann; Florian Kälble; Christian Morath; Volker Eckstein; Anthony Ho; Carsten Mueller-Tidow; Stefan Meuer; Karsten Mahnke; Claudia Sommerer; Martin Zeier; Andrea Steinborn
Journal:  Immunology       Date:  2018-05-25       Impact factor: 7.397

3.  Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients.

Authors:  Matthias Schaier; Claudius Gottschalk; Lorenz Uhlmann; Claudius Speer; Florian Kälble; Volker Eckstein; Carsten Müller-Tidow; Stefan Meuer; Karsten Mahnke; Hanns-Martin Lorenz; Martin Zeier; Andrea Steinborn
Journal:  Arthritis Res Ther       Date:  2018-12-18       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.